HYSQ, GENE, ASTM, etc. I noticed heavy volume on HYSQ and GENE on Thursday, and did not know why. Over the weekend, CNN had a big feature on gene therapy. I suspect this is probably part of the reason. Also, apparently either Time or Newsweek, or both, are having big stories on gene therapy and similar subjects this week. So, I suspect these, and other biotechs, could be in for nice gains this week. (And, nice gains this year, too, as you point out.) I also like CTII, although I don't have any at the moment, as well as GERN. I had some GERN, but I sold it at the last pop. Waiting for the price to get back below $10 before buying any more.
Ed
|
